SKYSEQ

Trademark usage description

integrated and high-throughput screening technologies coupled with next-generation sequencing for research and development of pharmaceuticals, namely, Read More

Classification Information

Class [042]
Integrated and high-throughput screening technologies coupled with next-generation sequencing for research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases.

Classification kind code

Mark Details

Serial Number

2094838

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 21^st Nov 2024	Search Recorded
Submitted for opposition 20 on 21^st Nov 2024	Examiner's First Report
Submitted for opposition 135 on 22^nd Feb 2024	Amendment to Application
Submitted for opposition 135 on 10^th Jan 2024	Amendment to Application
Submitted for opposition 287 on 29^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 25^th Mar 2021	Filed
Submitted for opposition 1 on 25^th Mar 2021	Created
Submitted for opposition 31 on 25^th Mar 2021	Formalized